The global optogenetics market is the rising use of optogenetics in the field of neuroscience. New developments in optogenetics such as wireless microchips have enabled convenient treatment of conditions, including depression and Parkinson’s disease. According to World Health Organization (WHO) in 2017, it is estimated around 300 million people were affected by depression globally which makes it the main cause of disability such as decrease in self-esteem, feeling bored and loss of a direction or purpose.
Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/1097
Furthermore, rampant advancements in technology such as ultrafast laser tools, LEDs, ytterbium-based lasers are the other factors responsible in driving the growth of optogenetics market. However, reluctance in adoption of new technology by healthcare professionals due to high costs in the deployment of technology, lack of awareness regarding the tools in emerging economies, and lack of availability of genetic reagents that can be conveniently used for probing biological processes are factors hindering growth of the optogenetics market.
Optogenetics technology is used by placing the genes that express light-sensitive proteins into mammalian cells, which normally lack such proteins. When the proteins are illuminated with specific wavelengths of light, they change the behavior of the cells, thereby introducing certain types of ions or pushing out a few to alter electrical activity.
Furthermore, optogenetics has also been used in the treatment of retinal disease and hearing impairment. Advancements in optogenetics technology has led to a sound understanding of neuroscience. Presently, multiphoton excitation microscopy is the technique that is used for investigating optogenetic studies of live animal brain at single neuron resolution.
Purchase a copy of Optogenetics Market Research: https://www.coherentmarketinsights.com/insight/buy-now/1097
According to Montreal Neurological Institute, the light treatment therapy has the ability to control virtually any type of neuron in the brain with pulses of light, thus making it precise both, in terms of timing and type of cells affected. Thus, optogenetics has proved to have a much more targeted approach to chronic pain relief than the conventional methods, which cannot be localized with the same precision as a beam of light. Furthermore, Asia Pacific is expected to hold a major market share in the global optogenetics market during the forecast period, primarily attributed to increasing adoption of optogenetic techniques and ultrafast laser tools by several neuroscience labs.
For instance, Coherent Inc. launched a new type of short pulse ultrafast laser sources that provides wide wavelength (680-1300nm) tunability of the primary output as well as simultaneous high power (1.5 watts) output at 1040 nm. Furthermore, this combination makes lasers such as Chameleon Discovery ideal for demanding multiphoton excitation application in optogenetics.
Browse the Full Report https://www.coherentmarketinsights.com/ongoing-insight/optogenetics-market-1097
Key players in the optogenetics market include Coherent, Inc., Thorlabs, Inc. Cobalt, Inc., Scientifica, Laserglow Technologies, Regenxbio, Inc., Gensight, Addgene, UPenn Vector Core, and Jackson Laboratories. The key players are focusing on strategic mergers and acquisitions and development of innovative systems.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Subscribe to our newsletter to get notification about new updates,information, discount, etc..